KATRINA RICHARDSON: Open Payments
NPI 1053399337 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 15 payments from 7 companies in 2025. Trend: 2023 $415 · 2024 $1,117 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $183 |
| Alkermes, Inc. | 3 | $167 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
Products named: ABILIFY MAINTENA, LYBALVI, UZEDY, CAPLYTA, ARISTADA, COBENFY, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE.
Industry payments across MI — which companies pay providers there.
